Berman, M.; Ben-Ami, R.; Berliner, S.; Anouk, M.; Kaufman, I.; Broyde, A.; Borok, S.; Elkayam, O.
The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature. Life 2021, 11, 258.
https://doi.org/10.3390/life11030258
AMA Style
Berman M, Ben-Ami R, Berliner S, Anouk M, Kaufman I, Broyde A, Borok S, Elkayam O.
The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature. Life. 2021; 11(3):258.
https://doi.org/10.3390/life11030258
Chicago/Turabian Style
Berman, Mark, Ronen Ben-Ami, Shlomo Berliner, Marina Anouk, Ilana Kaufman, Adi Broyde, Sara Borok, and Ori Elkayam.
2021. "The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature" Life 11, no. 3: 258.
https://doi.org/10.3390/life11030258
APA Style
Berman, M., Ben-Ami, R., Berliner, S., Anouk, M., Kaufman, I., Broyde, A., Borok, S., & Elkayam, O.
(2021). The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature. Life, 11(3), 258.
https://doi.org/10.3390/life11030258